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The effect of nucleotides on binding of the B2 kinin
(BK) receptor agonist [3H]BK and the antagonist
[3H]NPC17731 to particulate fractions of human fore-
skin fibroblasts was studied. At 0°C, particulate frac-
tions exhibited a single class of binding sites with a Kd
of 2.3nM for [3H]BK and a Kd of 3.8nM for the antagonist
[3H]NPC17731. Incubation with radioligands at 37°C
for 5 min gave a reduction of agonist, as well as antag-
onist, binding that was between 0–40% depending on
the preparation, even in the absence of guanosine 
nucleotides. As shown by Scatchard analysis, this
reduction in specific binding was due to a shift in the
affinity of at least a fraction of the receptors. The
presence at 37°C of the guanine nucleotides GTP, GDP
and their poorly hydrolyzable analogs left [3H]-
NPC17731 binding unaffected, but reduced the recep-
tor affinity for [3H]BK to a Kd of about 15 nM. The maxi-
mal number of receptors, however, was unchanged.
This affinity change was strongly dependent on the
presence of bivalent cations, in particular Mg2+. It was
reversed by incubation at 0°C. The rank order of the
guanosine nucleotides for [3H]BK binding reduction
was GTP[S] = Gpp[NH]p  GTP = GDP  GDP[S].
GMP, ATP, ADP and AMP showed no influence on ago-
nist binding. A model for the interaction of the B2 kinin
receptor with G proteins is discussed.
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Introduction
The nonapeptide bradykinin (BK) is released from high
molecular weight precursors, the kininogens, via the ac-
tion of proteolytic enzymes known as kallikreins. Gener-
ation of BK and or lysyl-BK (kallidin) frequently occurs in
response to tissue injury or inflammation, where these
peptides can exert a variety of biological effects, including
vasodilatation, increased vascular permeability, stimula-
tion of pain and hyperalgesia, and enhanced cell prolifera-
tion (Proud and Kaplan, 1988; Bhoola et al., 1992). Accord-
ing to pharmacological criteria, these effects are mediated
by at least two different receptors, B1 and B2 receptors
(Regoli and Barabe, 1988; Farmer and Burch, 1992). Radi-
oligand binding studies proved the existence of B2 recep-
tors in a variety of tissues and cell lines (Bathon and Proud,
1991). Recently the rat, mouse and human B2 kinin recep-
tors, as well as the human B1 kinin receptor, have been
cloned (McEachern et al., 1991; Hess et al., 1992; Menke
et al., 1994; Webb et al., 1994) and, based on sequence
homology, were grouped into the superfamily of the G pro-
tein-coupled receptors (GPCRs). These findings were in
agreement with previous reports, that BK, via the B2 re-
ceptor, is capable of activating phospholipase A and/or C
and of inhibiting adenylate cyclase via signal transduction
pathways that utilize guanosine nucleotide regulatory pro-
teins (Liebmann and Reissmann, 1990; Gutowski et al.,
1991; Liebmann et al., 1991; McEachern et al., 1991; Tipp-
mer et al., 1994). However, both the subtype of the G
protein(s) involved, as well as the effect of guanine nu-
cleotides on [3H]BK binding sites, are not completely un-
derstood. It has been reported that in human fibroblasts
(Etscheid and Villereal, 1989) and in bovine aortic en-
dothelial cells (Keravis et al., 1991) addition of guanosine
nucleotides may induce a reduction of B2 kinin receptor
number. In other studies, a change in affinity of B2 kinin re-
ceptors (Burch and Axelrod, 1987; Leeb-Lundberg and
Mathis, 1990; Liao and Homcy, 1993) or changes in both
affinity and receptor number (Mathis and Leeb-Lundberg,
1991) were reported. By contrast, guanosine nucleotides
were reported to inhibit [3H]BK binding to the human B2
kinin receptor expressed in COS-7 cells (Hess et al., 1992),
while no effect of these nucleotides was observed on BK
binding to receptors in guinea pig lung (Trifilieff et al.,
1994).
Cultured human foreskin fibroblasts express high num-
bers of B2 kinin receptor, which, when occupied by ago-
nist, are subject to strict regulatory control via internaliza-
tion and down-regulation (Roscher et al., 1984). Although
G proteins appear to couple these receptors to the syn-
thesis of eicosanoids, thereby accumulating cAMP and
the release of inositol phosphates (Roscher et al., 1983;
Burch and Axelrod, 1987; Dengler et al., 1990), little is
known regarding the exact mechanism of the interaction
between the B2 kinin receptor and these G proteins. In this
study, we compared the effect of guanine nucleotides on
B2 kinin receptor agonist and antagonist binding to partic-
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ulate fractions of human foreskin fibroblasts at 0°C and
at 37°C. 
We were able to demonstrate that at 37°C the guanosine
nucleotides GTP and GDP, and their hydrolysis-resistant
analogs, induce a reduction in affinity without a concomi-
tant loss of receptor number in the presence of agonist,
but not antagonist. This affinity reduction was reversible
by incubation on ice, indicating that at 0°C the B2 kinin
receptor is always in a high-affinity state and therefore
presumably coupled to a G protein.
Results
[3H]BK Binding to Particulate Fractions of
Human Foreskin Fibroblasts at 37°C in the Absence
and Presence of Gpp[NH]p 
Preliminary experiments with particulate fractions showed
that binding of [3H]BK, even in the absence of exogenous
guanosine nucleotides, rapidly decreased in some prepa-
rations with time at 37°C, but was stable in all preparations
at 0°C for at least three hours. Therefore, for experimental
convenience, all incubations were prepared on ice and
kept on ice for up to two hours until being used for studies
at 37°C. [3H]BK binding activity measured after a 90 min
incubation on ice was referred to as the maximum binding
capacity of the preparation used.
In Figure 1 the time course of specific [3H]BK binding at
37°C to a particulate fraction was followed in the absence
and presence of 100 M Gpp[NH]p. Two concentrations
(4nM and 0.35nM) of the radioligand were used. Maximum
[3H]BK binding measured with these concentrations by in-
cubation for 90 min on ice is shown in the graph at t = 0.
In the absence of Gpp[NH]p, specific [3H]BK binding
activity measured at 37°C reached a maximum value for
both concentrations after 5 min that declined with time. In
the presence of 100 M Gpp[NH]p, the binding activity for
both [3H]BK concentrations rapidly dropped within 2 min
at 37°C, reaching a plateau that remained almost un-
changed for the subsequent 60 min. This indicates that as-
sociation and binding reduction induced by the presence
of Gpp[NH]p had already reached an equilibrium 2 min
after warming up to 37°C. Therefore, all subsequent incu-
bations at 37°C were performed for 5 min, since at this
time point the reduction of specific [3H]BK binding by
GTP-analogs was already completed, and problems with
the spontaneous reduction of binding activity could also
be avoided. 
Effect of Mg2+ on Specific B2 Kinin Receptor Binding
in the Presence and Absence of 100 M Gpp[NH]p 
In the absence of Gpp[NH]p [3H]BK binding activity
reached a maximum at about 2 mM Mg2+ (Figure 2). Higher
concentrations of the divalent cation resulted in a slight
reduction of [3H]BK binding. In the presence of 100M
Gpp[NH]p a continuing reduction of [3H]BK binding with
increasing Mg2+ concentrations was observed. In the
absence of Mg2+ only a minor difference (or none in some
experiments) between [3H]BK binding activity in the pres-
ence and absence of Gpp[NH]p was obtained. A maxi-
mum decline in binding activity induced by Gpp[NH]p was
observed at Mg2+ concentrations higher than 10mM (Fig-
ure 2, inset). Therefore, all assays were performed in the
presence of 25mM MgCl2 unless otherwise indicated. The
divalent cation Ca2+ similarly supported the reduction of
binding induced by Gpp[NH]p (not shown).
Fig.1 Time Curve of [3H]BK Binding to Particulate Fractions in
the Presence and Absence of Gpp[NH]p.
Aliquots of a particulate fraction were incubated with 0.35nM (,
) and 4 nM (, ) [3H]BK in the absence (, ) or presence (, )
of 100M Gpp[NH]p at 37°C for the indicated times or at 0°C for
90 min (t = 0). Thereafter specific binding was measured as de-
scribed under Materials and Methods. Values represent the mean
of triplicate determinations. Three other experiments gave similar
results, with the exemption to the difference between binding at
0°C after 90 min and 37°C at 5 min.
Fig.2 Influence of Mg2+ on [3H]BK Binding in the Absence and
Presence of Gpp[NH]p.
Aliquots of a particulate fractions were incubated with 1.2nM
[3H]BK and the indicated concentrations of Mg2+ added as chlo-
ride salt, for 5 min at 37°C in the absence () or presence () of
100M Gpp[NH]p. Subsequently, specific binding was measured
as described under Materials and Methods. Values represent the
mean of triplicate determinations. A representative experiment
out of four is shown.
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Effect of Gpp[NH]p on [3H]BK Binding Activity at
0°C and 37°C 
In the experiment shown in Figure 3 [3H]BK binding activi-
ty, measured after an incubation for 5 min at 37°C, was
reduced to about 80% of the value obtained after an incu-
bation for 90 min at 0°C. This difference between binding
activity at 0°C and 37°C, however, was very variable from
one assay to another. Some preparations showed ab-
solutely no difference whereas others revealed at 37°C
only 60% of the binding activity as compared to that ob-
tained at 0°C (not shown). Technical reasons such as the
temperature during the preparation, the volume of buffer
the cells were suspended in, the time of sonification or
centrifugation, the protein amount in the assay, or the in-
fluence of reducing agents (addition of dithiothreitol and
mercaptoethanol) were excluded as the cause for this in-
terassay variability (not shown). The presence of 100M
Gpp[NH]p at 37°C led to a further reduction of [3H]BK
binding to about 30% of the control value obtained at 0°C.
Interestingly, both reducing effects on [3H]BK binding, the
one in the absence (not shown) and the one in the pres-
ence of Gpp[NH]p, were slowly reversed by a subsequent
incubation at 0°C. The full complement of receptor bind-
ing activity was restored within 90 min (Figure 3) at 0°C.
A second incubation at 37°C again induced a reduction in
[3H]BK binding that was similar to the initial effect (Fig-
ure 3, last column).
Reduction of [3H]BK Binding by Various 
Nucleotides 
Increasing concentrations of various nucleotides were
tested for their capability to reduce [3H]BK binding in par-
ticulate fractions (Figure 4). Increasing concentrations of
all the guanosine nucleotides tested reduced [3H]BK bind-
ing in a dose-dependent fashion. The poorly hydrolyzable
nucleotides GTP[S] and Gpp[NH]p were most efficient
with a half-maximal effect at concentrations less than
1M, followed by GTP and GDP with a half-maximal effect
at about 3M. The poorly hydrolyzable compound GDP-
[S] gave this effect only at concentrations higher than
10M. Maximal reduction was comparable for all nu-
cleotides tested in this experiment, reaching about 30% of
the control value obtained in the absence of nucleotides.
No reduction was observed by addition of adenosine nu-
cleotides (ATP, ADP, AMP) or GMP even at high concentra-
tions of 1mM (not shown). Since we found no differences
in any of our experiments between GTP[S] and Gpp[NH]p
in terms of reduction of [3H]BK binding, we used Gpp[NH]p
for the subsequent experiments.
Equilibrium Analysis of [3H]BK (Agonist) and
[3H]NPC17731 (Antagonist) Binding to Particulate
Fractions: Effect of Gpp[NH]p 
Equilibrium binding of the B2 kinin receptor agonist [3H]BK
to aliquots of a particulate fraction as a function of [3H]BK
concentration is shown in Figure 5 A. At 0°C Gpp[NH]p
had no effect on [3H]BK binding (not shown). The binding
curves were steep in the absence of Gpp[NH]p at 0°C as
well as at 37°C, reaching a plateau at [3H]BK concentra-
tions higher than 15 nM. In the presence of Gpp[NH]p at
37°C the binding curve was less steep. Scatchard analy-
sis of these data revealed different receptor affinities, but
no difference in maximal binding capacity (Figure 5 A, in-
set). Only a single category of binding sites with a Kd of 2.1
nM was found for [3H]BK binding at 0°C. At 37°C, in the ab-
sence of Gpp[NH]p, the Scatchard curve was more com-
plex indicating the presence of more than one binding site.
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Fig.3 [3H]BK Binding Activity at 0°C and 37°C in the Presence
and Absence of Gpp[NH]p.
Aliquots of a particulate fraction were incubated with 2.1nM
[3H]BK in the absence (–) or presence (+) of 100M Gpp[NH]p at
0°C for 90 min or at 37°C for 5 min followed by an incubation at
0°C for the time indicated. In the incubation depicted on the last
column reaction vials were again incubated at 37°C for 5 min.
Thereafter specific binding was measured as described under
Materials and Methods. Values represent the mean of triplicate
determinations. Another experiment gave similar results.
Fig.4 Inhibition of Specific [3H]BK Binding by Guanosine Nu-
cleotides.
Aliquots of a particulate fraction were incubated with 2 nM [3H]BK
and the indicated concentrations of guanosine nucleotides for
5 min at 37°C. Thereafter specific binding was measured as de-
scribed under Materials and Methods. Values represent the mean
of triplicate determinations. () GTP[S], () Gpp[NH]p, () GTP,
() GDP, () GDP[S]. For each nucleotide at least one other
experiment was performed with similar results.
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In the presence of 100M Gpp[NH]p, however, apparently
only a single binding site with an affinity of about 15 nM was
observed at 37°C.
Equilibrium binding isotherms of the B2 kinin receptor
antagonist [3H]NPC17731 at 0°C and 37°C in the pres-
ence and absence of 100M Gpp[NH]p are shown in
Figure 5 B. The binding curve obtained at 0°C is distinctly
steeper than the curves obtained at 37°C, which exhibited
a similar course regardless of the presence of 100M
Gpp[NH]p. The Scatchard analysis of these data revealed
only a single binding site for antagonist binding at 0°C with
an apparent Kd of 3.8nM. At 37°C, however, the Scatchard
plot exhibits a bound curve in the absence of Gpp[NH]p,
indicating more than one binding site. In addition, this
curve was almost identical to the one obtained at 37°C in
the presence of Gpp[NH]p, confirming that antagonist
binding to B2 kinin receptors is not affected by guanosine
nucleotides. 
Dissociation Kinetics of [3H]BK in the Absence and
Presence of 100 M Gpp[NH]p at 37°C 
In order to test whether the reduction of B2 kinin receptor
affinity by guanosine nucleotides is due to an increase in
the dissociation rate, particulate preparations were incu-
bated with [3H]BK for 5 min at 37°C in the presence and
absence of Gpp[NH]p. Dissociation was then induced by
addition of unlabeled BK (Figure 6). [3H]BK dissociated
rapidly in the presence and absence of Gpp[NH]p, where-
as control binding remained almost unchanged. The semi-
logarithmic plot of the data, normalized to the initial value
as 100% (Figure 6, inset), however, clearly shows that the
dissociation is faster in the presence than in the absence
of Gpp[NH]p.
Fig.5 Equilibrium Binding of Agonist [3H]BK and Antagonist
[3H]NPC17731 as a Function of Ligand Concentration.
(A) Aliquots of a particulate fraction were incubated with increas-
ing concentrations of [3H]BK (0.17–38.4nM) for 5 min at 37°C (,
) or for at least 90 min at 0°C () in the absence (, ) or pres-
ence () of 100M Gpp[NH]p. Thereafter specific binding was
measured as described under Materials and Methods. Each point
represents the mean of triplicate determinations. Inset: Scatchard
plot of the data. The lines for the data at 0°C in the absence of
Gpp[NH]p and at 37°C in the presence of Gpp[NH]p were com-
puted by linear regression analysis. The equilibrium dissociation
constants estimated from the slopes (–1/Kd) were 2.0  0.5 nM for
binding at 0°C and 13.8  1.1 nM for binding at 37°C in the pres-
ence of 100M Gpp[NH]p. The average values including other ex-
periments gave a Kd of 2.3  0.4 nM (mean  S.E, n = 4) for bind-
ing at 0°C and 14.6  4 nM (mean  S.E., n = 3) for binding at 37°C
in the presence of 100M Gpp[NH]p or GTP[S] (n = 3). (B) A sim-
ilar experiment is shown with increasing concentrations of antag-
onist NPC17731 (0.05–36.4 nM). Symbols have the same mean-
ing as described in (A). Inset: Scatchard plot of the data in (B). 
The equilibrium dissociation constant estimated from the slope
(–1/Kd) was 3.8  0.12 nM. A second experiment gave similar re-
sults. Scatchard analysis using the Enzfitter program did not give
reasonable results for agonist and antagonist binding at 37°C in
the absence of Gpp[NH]p, when proposing one binding site or
two binding sites with different affinities.
Fig.6 Dissociations Kinetics of [3H]BK in the Absence and
Presence of Gpp[NH]p.
Aliquots of a particulate fraction were incubated with 2.1nM
[3H]BK in the absence (, ) or presence (, ) of 100M
Gpp[NH]p for 5 min at 37°C. Dissociation (, ) at 37°C was ini-
tiated by addition of unlabeled BK (5M final concentration). Spe-
cific binding was measured at the indicated times as described
under Materials and Methods. Control values without addition of
BK are also shown (, ). Values represent the mean of triplicate
determinations. Inset: Semi-logarithmic plot of the dissociation
data, normalized to the control values at t = 0, using the same
symbols.
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Discussion
Depending on the tissue source or cell line under study BK
is reported to stimulate, or to inhibit, a variety of signal
transduction pathways. The role of G proteins, however, in
the variety of BK signal cascades is not fully elucidated.
Human foreskin fibroblasts expressing high numbers of
B2 kinin receptor have already been shown to be an ex-
cellent tool to study the regulation and the properties of
the human B2 kinin receptor, as well as its signal transduc-
tion pathways (Roscher et al., 1983, 1984; Dengler et al.,
1990; Faussner et al., 1991). Therefore, we decided to use
this cell system to investigate the regulatory role of guano-
sine nucleotides in the binding of agonist and antagonist
to B2 kinin receptors in particulate fractions of human
foreskin fibroblasts.
In the presence of GTP, GDP, and their poorly hydrolyz-
able analogs there was a reduction in agonist ([3H]BK), but
not antagonist ([3H]NPC17731) binding affinity in particu-
late fractions of human forskin fibroblasts at 37°C.
This effect was dependent on the presence of divalent
cations, particularly Mg2+. In the absence of Mg2+ there
was only a minimal reduction of binding activity upon ad-
dition of guanosine nucleotides. This dependence on di-
valent cations may explain the observed lack of reduction
of [3H]BK binding to guinea pig lung membranes by GTP
analogs (Trifilieff et al., 1994), since Mg2+ was not included
in the incubation buffer in these studies. As suggested by
Keravis et al. (1991), the regulation of receptors by G pro-
teins may vary depending on differences in species or tis-
sues. They observed an inhibition of BK binding to B2 kinin
receptors in membranes of bovine endothelial cells by
GTP, GDP, GTP[S], and GDP[S]. This inhibitory effect,
however, did not depend on the presence of Mg2+. Indeed,
in contrast to our results in fibroblasts, the described
effect was almost completely blocked by addition of 5 mM
MgCl2 or 5 mM CaCl2. In particulate fractions of fibroblasts
we found only a single binding site with a Kd of 2.3 nM in the
presence of 25 mM Mg2+ at 0°C. As already described for
other B2 kinin receptor assays, Mg2+ (25mM) reduced
agonist affinity, since we obtained a higher Kd of 0.7nM
at 0°C in the absence of Mg2+ (not shown).
A spontaneous reduction of binding activity was ob-
served for agonist and antagonist upon incubation at
37°C. Scatchard analysis of equilibrium binding curves
revealed that the reduction in binding activity is the con-
sequence of a change in the affinity of at least a part of the
receptors and is not due to a decrease in receptor number.
Thus, one can assume that under certain conditions B2
kinin receptors in particulate fractions can change their
affinity even in the absence of exogenous guanosine
nucleotides. Addition of GTP derivatives led to a further
reduction of agonist binding but not antagonist binding.
Scatchard analysis of equilibrium binding of agonist
([3H]BK) and antagonist ([3H]NPC17731) binding revealed
that at 0°C there is only one single category of binding
sites with a dissociation constant (Kd) of 2.3  0.4 nM
(mean ± S. E., n = 4) for [3H]BK and a Kd of 3.8/5.2nM (n = 2)
for [3H]NPC17731. In membranes of bovine aortic en-
dothelial cells the existence of a high-affinity B2 bind-
ing site has been reported for BK at 0°C, that even at this
temperature in the presence of 100 M Gpp[NH]p is
changed to a low-affinity site by incubation for 90 min
(Liao and Homcy, 1993). Our results with foreskin fibro-
blasts are completely different, since incubation at 0°C
actually reversed a prior change in affinity induced at 37°C
(Figure 3). This different influence of the temperature on B2
kinin receptor affinity reduction by guanosine nucleotides
may reflect a species-specific difference or might be due
to coupling of the B2 kinin receptor to different G proteins
in different cell types. 
The binding reduction observed for agonist and antag-
onist binding after an increase of temperature from 0°C to
37°C seems to be due to the change in the affinity of a part
of the receptors, as can be seen from the Scatchard plots.
In the presence of GTP[S] or Gpp[NH]p at 37°C only
a low-affinity site for the agonist with a Kd of 14.6 
4 nM (mean  S. E., n = 3) was seen. Dissociation kinetics
demonstrate that this reduction of receptor affinity by
guanosine nucleotides is due to an increase of the dis-
sociation rate for [3H]BK (Figure 6), as also suggested by
other reports (Leeb-Lundberg and Mathis, 1990). These
results clearly indicate that in human foreskin fibroblasts
G proteins influence the affinity but not the number of B2
kinin receptors in particulate fractions. This is in contrast
to previous results reported by others (Etscheid and Ville-
real, 1989) who observed a 45% reduction in B2 kinin
receptor number in the presence of 100M GTP[S] in
human foreskin fibroblasts. 
GTP, GDP and their poorly hydrolyzable analogs
GTP[S], Gpp[NH]p and GDP[S] were all capable of re-
ducing [3H]BK binding in particulate fractions; the poorly
hydrolyzable analogs GTP[S] and Gpp[NH]p showed
highest potencies with IC50 values around 1M, followed
by GTP and GDP (IC50 about 3M) and GDP[S] (IC50
about 10M). GMP and adenosine nucleotides (ATP, ADP,
AMP) showed no effect (not shown). Similar potencies of
these nucleotides have been reported for the reduction of
B2 kinin receptors in bovine endothelial cells (Keravis et
al., 1991), for the -adrenergic receptor (Lefkowitz et al.,
1976), and for the -adrenergic receptor (Rouot et al.,
1980). The observation that not only GTP but also GDP
exerts a strong effect on agonist binding to B2 kinin re-
ceptors has important implications when considering any
hypothesis for the interaction of the B2 kinin receptor with
G proteins.
Results derived from dissociation studies in the pres-
ence and absence of Gpp[NH]p (Leeb-Lundberg and
Mathis, 1990) led to the suggestion that the B2 kinin re-
ceptor may exist in at least two different states that display
different affinities depending on coupling to a G protein. In
bovine myometrium, the B2 kinin receptor has been sug-
gested to exhibit a high-affinity binding site when coupled
to a G protein, and a low-affinity binding site when uncou-
pled. Building on this assumption, the similar effects of
GTP and GDP in our current study may be explained by the
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existence of an intermediate ternary complex of agonist,
receptor and G protein, that is only stable in the absence
of GTP and GDP as suggested by others (De Lean et al.,
1980; Haga and Haga, 1987; Keravis et al., 1991). Since
GTP and GDP are almost completely lost during the
preparation of the particulate fraction, the receptor should
remain coupled to the G protein while exhibiting high affin-
ity for the agonist. Under these circumstances our results
would imply that GTP or GDP are able to bind to the G
protein in this ternary complex only in the presence of an
agonist and thereby promote dissociation of the ternary
complex. One would also expect neither binding of
GTP/GDP to the ternary complex at 0°C nor dissociation
of this complex, since receptor affinity was not influenced
at this temperature. 
At 0°C the agonist binds to B2 kinin receptors only with
high affinity. The same appears to be the case for antago-
nist binding. This, however, can be only deduced indirect-
ly by the fact that an increase of temperature from 0°C to
37°C leads to lower affinities for antagonist binding (Fig-
ure 5 B) without apparent loss in receptor number. Several
other experiments using antagonist concentrations close
to 3 nM at 37°C gave variable binding reductions, ranging
between 0% and 40% as compared to values obtained at
0°C. Experiments were performed with prior incubation of
particulate fractions with 0.5nM unlabeled BK in the ab-
sence (mainly high-affinity state) and presence of 100M
Gpp[NH]p for 5 min (to induce the low-affinity state). Sub-
sequent assays for 5 min at 37°C with 8nM [3H]NPC17731
resulted in almost identical antagonist binding activities in
both pretreatment groups (not shown). This may suggest
that antagonist binding is capable of reversing the affinity
reduction, induced by an agonist in the presence of
guanosine nucleotides, or that a B2 kinin receptor after
dissociation of the agonist immediately returns to its high-
affinity conformation. A third explanation taking into ac-
count the different consequences of mutations on agonist
and antagonist binding (Nardone and Hogan, 1994) may
be that the antagonist is not able to differentiate between
the high- and the low-affinity states.
Taken together these results are best explained by a
model (Figure 7) in which B2 kinin receptors (R) are pre-
coupled to G proteins (G) with an empty guanosine nu-
cleotide binding site in the absence of agonist (B) as well
as in the presence of antagonist (N). The preceding release
of GDP from this receptor-G protein-complex should be
fast, not depending on the presence of an agonist. This
proposal is also supported by the results of Mathis and
Leeb-Lundberg (1991) showing a sensitivity to Gpp[NH]p
of soluble B2 kinin receptors of bovine myometrium even
when the receptors have been solubilized in the absence
of agonist. We have previously shown that gel filtration of
B2 kinin receptors solubilized from human foreskin fibrob-
lasts (Faussner et al., 1991) gave an apparent molecular
mass for the B2 kinin receptor that was much higher (ap-
proximately 250 kDa) than would be expected by the cal-
culated molecular mass of 41 kDa deduced from cDNA
analysis (Hess et al., 1992) or by the molecular mass of
about 68 kDa that has been found by immunoprecipitation
and affinity cross-linking (Abd Alla et al., 1993). This fact
may well be due to co-solubilization of coupled G pro-
tein(s). According to the model in Figure 7, one could
speculate that the major task of an agonist is to open the
receptor-coupled G protein for binding of either GTP or
GDP. Only binding of GTP would relay a signal; however,
due to the prevalence of this guanosine nucleotide in the
cell this is almost always the case. Furthermore, opening
of the G proteins for guanosine nucleotides by agonists
should happen only at 37°C, but not at 0°C, and should be
blocked by occupation of the receptor with antagonist.
Therefore, one can assume that in the absence of an
agonist and in the presence of an antagonist, or at 0°C, a
complex is formed consisting of G proteins having no
guanosine nucleotide bound and of B2 kinin receptors
exhibiting a high-affinity binding for agonist as well as for
antagonists. This would explain the co-solubilization of B2
kinin receptors and G proteins. A recent publication de-
scribing that antagonists like NPC17731 and Hoe140 may
act as inverse agonists in rat myometrial cells supposed
that the antagonists bind to and stabilize a G protein un-
coupled state of the B2 kinin receptor (Leeb-Lundberg et
al., 1994). It should therefore be a low-affinity binding
state, always provided that the antagonist is able to dis-
criminate between high- and low-affinity states. In our
opinion, however, these data do not demonstrate experi-
mentally that the antagonists preferentially bind to the G
protein uncoupled state. The reported fact that antago-
nists may act as inverse agonists could also be explained
by the assumption of a spontaneous opening of the G pro-
tein for GTP in the coupled, unoccupied receptor state,
Fig.7 Proposed Model for the Interaction of the B2 Kinin Re-
ceptor with a G Protein.
B, agonist; N, antagonist; RH high-affinity receptor; RL, low-affini-
ty receptor; GØ, G protein without and inaccessible for guanosine
nucleotide; GØ*, G protein without bound, but accessible for
guanosine nucleotide. The model is explained in the Discussion
section.
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leading to the dissociation of an activated G protein. If oc-
cupation of the receptor with an antagonist reduces this
spontaneous activation of the coupled G protein, this an-
tagonist would behave like an inverse agonist.
Transfer of the C-terminus of the internalizing B2 kinin
receptor to the normally not internalizing B1 kinin receptor
resulted in almost completed transfer of the internalization
pattern, i. e. the receptor chimera responded to stimula-
tion with a B1 kinin receptor agonist with fast receptor in-
ternalization (Faussner et al., 1998), despite the fact that
the two receptors have only an overall homology of 36%
and even less when comparing only the intracellular do-
mains. This result could be easily explained assuming that
the internalization process does not require a specific in-
teraction of the remaining part of the receptor with its C-
terminus but requires only access of the internalization
machinery to the C-terminus. In the proposed model of a
precoupled receptor this access, however, would sterical-
ly be blocked by the G protein, thus allowing receptor in-
ternalization only after agonist stimulation and following
activation/release of the blocking G protein.
Our model shown in Figure 7 contrasts somewhat to
models developed for other G protein-coupled receptors
(e.g. the muscarinic receptor, where coupling to G pro-
teins is supposed to be a consequence of agonist binding;
De Lean et al., 1980; Haga and Haga, 1987; Freissmuth 
et al., 1989). Nonetheless, since the G protein-coupled re-
ceptors apparently not even share the same seven-trans-
membrane domain structure as indicated by the fact that
the B2 kinin receptor in particular apparently does not
have three but only two internal loops (Quitterer et al.,
1999) and that they are composed of internal loops and 
C-termini of very different amino acid composition and




[2,3-prolyl-3,4-3H]bradykinin (108 Ci/mmol) and [prolyl-3,4-3H]-
NPC17731 (48.5 Ci/mmol) were obtained from Du Pont-New
England Nuclear (Boston, MA, USA). All nucleotides were from
Boehringer Mannheim (Mannheim, Germany). Unlabeled BK and
all other reagents were from Sigma (Deisenhofen, Germany).
Hoe140 was a gift from Dr. B. Schoelkens (Hoechst, Frankfurt,
Germany).
Cell Culture 
Two lines of foreskin fibroblasts (# 7241 and #1634) were pur-
chased from ATCC (Rockville, MD, USA). Cells were used be-
tween the 5th and 19th passage. Stock cultures were grown in
Eagle’s basal medium supplemented with Earle’s salts, 10% fetal
calf serum, and 2 mM glutamine, as described previously (Fauss-
ner et al., 1991). For all experiments confluent stock cultures were
trypsinized and split 1:5–1:8 on tissue culture dishes (100 or 
145 mm diameter). Medium was changed after 4–7 days and
subcultures were used upon reaching confluence usually 7 to 
14 days after seeding.
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Preparation of Particulate Fibroblast Fractions 
Confluent cell monolayers were washed with a hypotonic solution
(H2O) at room temperature and scraped off in ice-cold 20mM
PIPES-buffer, adjusted to pH 6.8 with KOH, containing 2mM bac-
itracin and 25mM MgCl2 (PBM-buffer), and disrupted by sonifi-
cation. Thereafter, the homogenate was centrifuged at 4°C at
30000 g for 15 min. For radioligand binding studies the pellets
were resuspended by sonification in ice-cold PBM-buffer (unless
otherwise indicated).
Binding Assay with [3H]BK or [3H]NPC17731 
Binding of [3H]BK and [3H]NPC17731 to homogenates and par-
ticulate fractions of fibroblasts was performed as described pre-
viously (Faussner et al., 1991) with slight modifications. 100 or
200 l of an ice-cold suspension of a particulate fraction, corre-
sponding to 15–45g protein, were added to reaction vials
placed on ice. Nucleotides and other agents were added as 100-
fold concentrated solutions, while MgCl2 6H2O and CaCl2 
2H2O were added as 50-fold concentrated solutions, as indicat-
ed in the Figure legends. A volume equal to that of the particulate
fraction of PBM-buffer was added containing appropriate con-
centrations of [3H]BK or [3H]NPC17731 without (for determination
of total binding), or with 5M unlabeled BK or 5M Hoe140 (in
antagonist studies) for determination of nonspecific binding. For
binding studies at 0°C, the incubation mixture was shaken and
further incubated for at least 90 min on ice. Binding studies at
37°C were performed by transferring the ice-cold incubation mix-
ture to a water bath. Incubations were then continued for 5 min
unless otherwise indicated. Separation of protein-bound ligand
from free ligand was obtained by rapid filtration through glass
fiber filters (Whatman GF/C), presoaked in ice-cold 0.3% poly-
ethylenimine. The filters were rapidly washed with ice-cold 14%
isopropyl alcohol (3  4 ml), using a filtration device (Hoeffer In-
struments, San Francisco, CA, USA) and the filter-bound radio-
activity was determined after addition of 3 ml scintillation liquid.
Specific binding was calculated as the difference between total
and nonspecific binding. In typical experiments using [3H]BK at a
concentration of approximately 2nM, nonspecific binding was
less than 20% of total binding; that of [3H]NPC17731 at a concen-
tration of 4nM was less than 30%. Data calculation and best curve
fits were made using the Enzfitter program from Biosoft (Fergu-
son, MO, USA).
Protein Determination
Concentrations of protein were measured according to the
method of Bradford using bovine serum albumin as a standard
(Bradford, 1976).
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